Momemtum Medical Supply Inc is categorized under Medical Apparatus and Supplies in Houston, TX and active since 2007.
Momemtum Medical Supply Inc was established in 2007, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Medical Apparatus and Supplies business, which does work in the B2C market, and is classified as a Medical Apparatus and Supplies, under code number 446199 by the NAICS.
If you are seeking more information, feel free to contact Kenneth Tetang at the company’s single location by writing to 6250 Westpark Drive # 113, Houston, Texas TX 77057 or by phoning (713) 334-2300. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Momemtum Medical Supply Inc |
Contact Person: | Kenneth Tetang |
Address: | 6250 Westpark Drive # 113, Houston, Texas 77057 |
Phone Number: | (713) 334-2300 |
Annual Revenue (USD): | $100.000 to $499.999 |
Founded: | 2007 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Medical Apparatus and Supplies |
SIC Code: | 5999 |
NAICS Code: | 446199 |
Share This Business: |
Momemtum Medical Supply Inc was started in 2007 to provide professional Medical Apparatus and Supplies under the SIC code 5999 and NAICS code 446199. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Kenneth Tetang for inquiries that concern Momemtum Medical Supply Inc by calling the company number (713) 334-2300, as your correspondence is most welcome. Additionally, the physical location of the single location of Momemtum Medical Supply Inc can be found at the coordinates 29.723696,-95.494657 as well as the street address 6250 Westpark Drive # 113 in Houston, Texas 77057.
For its online presence, you may visit Momemtum Medical Supply Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.